Feature Channels: Vaccines

• share
• favorite_border

A nationwide survey of people who were pregnant or trying to become pregnant found that overall 54 percent expressed interest in the RSV vaccine during pregnancy. Perceiving RSV as a serious illness in infants was the strongest predictor of likely vaccination during pregnancy. Likelihood to receive the RSV vaccine during pregnancy was also higher among parents with a child at home already. Findings were published in the journal Pediatrics.

• share
• favorite_border

The Sabin Vaccine Institute presented the Albert B. Sabin Gold Medal to physician-researchers Keith Klugman and Shabir Madhi.

• share
• favorite_border

MD Anderson and CureVac today announced a co-development and licensing agreement to develop novel mRNA-based cancer vaccines.

• share
• favorite_border

Yale School of Medicine immunobiologist Akiko Iwasaki, PhD, will receive the 2024 Nakaakira Tsukahara Memorial Award from the Brain Science Foundation of Japan.

• share
• favorite_border

• share
• favorite_border

Most Republican voters support childhood vaccine mandates, yet may be discouraged from publicly expressing these views, a new study suggests.

• share
• favorite_border

Adding a personalized anti-tumor vaccine to standard immunotherapy is safe and about twice as likely to shrink cancer as standard immunotherapy alone for patients with hepatocellular carcinoma.

• share
• favorite_border

Wondering why some COVID-19 breakthrough cases feel milder than others? A groundbreaking study led by researchers at the Uniformed Services University (USU) sheds light on this phenomenon, offering insights into post-vaccination immunity dynamics.

• share
• favorite_border

Researchers at the Georgia Institute of Technology and the University of Wisconsin-Madison have developed a new vaccine that offers broad protection against not only SARS-CoV-2 variants, but also other bat sarbecoviruses.

• share
• favorite_border

Patient education about flu shot during a non-life threatening emergency department visit increases vaccination rates, especially in patients without regular primary care.

• share
• favorite_border

• share
• favorite_border

Researchers have identified a new complex-carbohydrate biomolecule, or glycan, that plays a key role in the nasal colonization of the Bordetella bacteria responsible for whooping cough. The discovery could make it possible to create a new drug or vaccine that interferes with the glycan to greatly reduce or even stop ongoing Bordetella transmission.

• share
• favorite_border

A vaccine against the bacterium that causes melioidosis was highly protective against the disease, which is endemic in many tropical areas, causing approximately 165,000 cases with 89,000 fatalities around the world each year. It is so dangerous that it is categorized as a Tier 1 Select Agent of bioterrorism.

• share
• favorite_border

Earlier this week, the Centers for Disease Control and Prevention, or CDC, issued an advisory to inform clinicians and public health officials of an increase in global and U.S. measles cases.

• share
• favorite_border

Researchers at the Institute of Human Virology (IHV) at the University of Maryland School of Medicine published a new study in the Journal of Infectious Diseases investigating the short-lived antibody response following SARS-CoV-2, the virus that causes COVID.

• share
• favorite_border

Text nudges encouraging people to get the COVID-19 vaccine, which had proven effective in prior real-world field tests, are also effective at prompting people to get a booster. The key in both cases is to include in the text a sense of ownership in the dose awaiting them.

• share
• favorite_border

Vaccine misinformation has gone mainstream—a post-pandemic reality that is putting more children at risk of exposure to potentially serious vaccine-preventable diseases like measles.

• share
• favorite_border

“We are hoping to use this competition not just as a way to examine the capacity of people to predict vaccination outcomes, but also as a way to address an important public health question,” says Peters.

• share
• favorite_border

Measles cases are being reported in different parts of the United States. David Nguyen, MD, a RUSH infectious disease physician who treats adults and children, answers the most common questions about the measles virus.

• share
• favorite_border

Calder Biosciences, Inc., a next-generation vaccine company, has been published in a Nature Communications article that debuts and validates the application of Calder's '3D Vaxlock' platform technology.

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

Four years ago, a brand new virus turned the world upside down. Today, we know more and can do more about the coronavirus called SARS-CoV2, and the disease called COVID-19, than ever before. A summary of the latest knowledge and guidance.

• share
• favorite_border

A recently published study that shows lactating mothers who get the COVID-19 booster pass along the antibodies to their children via their breast milk – and potentially protect babies too young to receive the vaccine.

• share
• favorite_border

Recent NCCN Guidelines updates—along with the supporting evidence—will be presented during the NCCN 2024 Annual Conference held in Orlando, Florida April 5-7, and simultaneously online. Visit NCCN.org/conference to learn more and register.

• share
• favorite_border

An international study has shown for the first time how empathetic correction of misinformation among vaccine-hesitant patients can significantly improve attitudes towards vaccination – and potentially boost vaccine uptake.

• share
• favorite_border

Young Anna Argyris, associate professor in the Michigan State University Department of Media and Information, is part of an international team studying the detrimental effects of vaccine misinformation on social media and interventions that can increase vaccine uptake behaviors.

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

Aproximadamente la mitad de la población mundial vive en zonas vulnerables a dengue, una infección viral potencialmente mortal transmitida a través de las picaduras de mosquitos infectados. No hay tratamiento, y solo las personas que ya han tenido dengue son elegibles para la vacuna.

• share
• favorite_border

• share
• favorite_border

As Canada’s flu season collides with record strep A cases and ongoing COVID-19 concerns, a new study is shedding light on our understanding of respiratory immune responses

• share
• favorite_border

Heightened use of social media during the coronavirus pandemic brought with it an unprecedented surge in the spread of misinformation.

• share
• favorite_border

New study results challenge the idea that vaccine immunity fades quickly

• share
• favorite_border

A highly contagious childhood disease once eradicated by vaccination has made a comeback.

• share
• favorite_border

Samara Rahman, 74, enrolled in a clinical trial at UCLA Health that was evaluating an “off-the-shelf” vaccine that is given after surgery to prevent or delay the cancer from coming back in high-risk patients.

• share
• favorite_border

• share
• favorite_border

Stay informed! These are the latest research articles on "Long COVID" from the Coronavirus News Source on Newswise.

• share
• favorite_border

• share
• favorite_border

No increased risks for babies, and for some serious neonatal complications lower risks.

• share
• favorite_border

While this expression has become an advertising slogan and meme, physicians and nurses continually rank among the most trusted professions in the U.S.